• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

An extended analysis of cardiovascular benefits of indoor air filtration intervention among elderly:a randomized crossover trial(Beijing indoor air purifier study,BIAPSY)

摘要Objective:Evidence on potential cardiovascular benefits of personal-level intervention among the elderly exposed to high levels of particulate matter(PM)remains limited.We aimed to assess improvements in surrogate markers of cardiovascular injury in vulnerable populations at risks by using indoor air filtration units.Methods:We conducted a randomized crossover trial for 2 separate 2-week air filtration interventions in 20 households of patients with stable chronic obstructive pulmonary disease and their partners in the winter of 2013,with concurrent measurements of indoor PM.The changes in biomarkers indicative of cardiac injury,atherosclerosis progression and systemic inflammation following intervention were evaluated using linear mixed-effect models.Results:In the analysis,average levels of indoor PM with aerodynamic diameters<2.5 μm(PM2.5)decreased significantly by 59.2%(from 59.6 to 24.3 μg/m3,P<0.001)during the active air filtration.The reduction was accompanied by improvements in levels of high-sensitivity cardiac troponin I by-84.6%(95%confidence interval[CI]:-90.7 to-78.6),growth differentiation factor-15 by-48.1%(95%CI:-31.2 to-25.6),osteoprotegerin by-65.4%(95%CI:-56.5 to-18.7),interleukin-4 by-46.6%(95%CI:-62.3 to-31.0)and myeloperoxidase by-60.3%(95%CI:-83.7 to-3.0),respectively.Conclusion:Indoor air filtration intervention may provide potential cardiovascular benefits in vulnerable popu-lations at risks.

更多
广告
作者 Jie Chen [1] Tong Wang [2] Hongbing Xu [2] Yutong Zhu [2] Yipeng Du [3] Beibei Liu [3] Qian Zhao [2] Yi Zhang [4] Lingyan Liu [2] Ningman Yuan [2] Jiakun Fang [2] Yunfei Xie [2] Shuo Liu [5] Rongshan Wu [6] Danqing Shao [7] Xiaoming Song [2] Bei He [3] Bert Brunekreef [8] Wei Huang [2] 学术成果认领
作者单位 Institute for Risk Assessment Sciences,Utrecht University,P.O.Box 80125,3508 TC Utrecht,The Netherlands;Department of Occupational and Environmental Health,School of Public Health,Peking University,Beijing 100191,China [1] Department of Occupational and Environmental Health,School of Public Health,Peking University,Beijing 100191,China;Peking University Institute of Environmental Medicine,Peking University,Beijing 100191,China;Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education,Peking University,Beijing 100191,China [2] Department of Respiratory Medicine,Peking University Third Hospital,Beijing 100191,China [3] Department of Occupational and Environmental Health,School of Public Health,Peking University,Beijing 100191,China [4] Department of Occupational and Environmental Health,School of Public Health,Peking University,Beijing 100191,China;Section of Environmental Health,Department of Public Health,University of Copenhagen,Copenhagen,1353 Copenhagen K,Denmark [5] Department of Occupational and Environmental Health,School of Public Health,Peking University,Beijing 100191,China;State Key Laboratory of Environmental Criteria and Risk Assessment,State Environmental Protection Key Laboratory of Ecological Effect and Risk Assessment of Chemicals,Chinese Research Academy of Environmental Sciences,Beijing 100012,China [6] Peking University Institute of Environmental Medicine,Peking University,Beijing 100191,China;Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education,Peking University,Beijing 100191,China [7] Institute for Risk Assessment Sciences,Utrecht University,P.O.Box 80125,3508 TC Utrecht,The Netherlands [8]
栏目名称 RESEARCH ARTICLES
发布时间 2022-06-20
提交
  • 浏览16
  • 下载1
全球健康杂志(英文)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷